Pharma Analytics:
AI-Driven Efficiency for Pharmaceutical & Biotech Companies

How Market Access Teams Verify Contracted Access Across Eligible Plans

Contracted access doesn’t guarantee that every eligible payer plan implements the agreed terms. This guide shows pharma market access teams how to verify contract clauses against plan-level policies, books of business, benefits, indications, and effective dates. Learn how to distinguish confirmed matches from implementation gaps, exclusions, and unresolved cases—and build an evidence-backed account brief that gives payer teams a clear path to resolution.

Why Invoices Get Blocked in Three-Way Matching, and How to Resolve Them

Blocked invoices often persist because the evidence needed to resolve them is scattered across invoices, purchase orders, receipts, and contracts. This guide explains how to resolve three-way match exceptions by linking records at the line level, identifying root causes and owners, validating prices against governing contracts, and routing corrections for review. It also shows how AI-powered spend validation can assemble evidence, surface discrepancies, and help AP and procurement teams clear exceptions faster while maintaining human approval.

Budget vs. Actual: How to Verify a Favorable Variance Before You Reforecast

A favorable budget variance isn’t automatically a saving. This guide shows FP&A teams how to verify budget vs. actual variances before reforecasting—reconciling GL data, distinguishing timing from permanent changes, tracing missing spend, and documenting open items. It also explores how AI-powered variance workflows can bring evidence together, investigate drivers, and draft finance commentary while keeping forecast decisions under human review.